Abbott Laboratories
Matrix initiated a new partial position in Abbott, a diversified healthcare company spanning medical devices, diagnostics, nutrition, and established pharmaceuticals. The firm…
ABT
5 published ideas on Abbott Laboratories across 4 funds — 5 long and 0 short.
Each entry below comes from a hedge fund's own investor letter, not a 13F filing, so it carries the reasoning behind the position on Abbott Laboratories: the full thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Matrix initiated a new partial position in Abbott, a diversified healthcare company spanning medical devices, diagnostics, nutrition, and established pharmaceuticals. The firm…
Davenport initiated Abbott Laboratories during the quarter, viewing it as a diversified healthcare franchise with a long record of dividend growth. The acquisition of Exact…
Matrix initiated a partial position in Abbott after a sharp pullback from its 52-week high. The fund likes Abbott's diversified healthcare businesses, recurring revenues, strong…
Matrix initiated a new partial position in Abbott, a diversified healthcare company spanning medical devices, diagnostics, nutrition, and established pharmaceuticals. The firm…
Matrix initiated a new partial position in Abbott Laboratories after a significant share-price pullback. The fund likes Abbott's diversified healthcare businesses, recurring…